Pluristem Therapeutics Inc (PSTI)

[FDApproved]

Mesenchymal Stem/stromal Cells (MSCs) or exosomes for disease or injury modification

There is discussion in the stem cell field about what product will be best for treating different disease indications- MSCs or their exosomes? There are pros and cons to each product, and one might be better than the other for the treatment of specific diseases or tissue injuries. For instance, exosomes might replace the functions of IV-administered MSCs for treating Graft vs. Host disease or for other immunomodulatory functions, whereas for tissue or bone repair MSCs injected locally and engineered to be retained for longer periods of time might be best, to orchestrate healing.

https://academic.oup.com/stmcls/pages/call-for-papers?login=false